바로가기
메인메뉴로 바로가기
콘텐츠 바로가기
하단메뉴로 바로가기
패밀리사이트 바로가기


진료과

  • 연세암병원-간암센터

전문진료분야

  • <소화기내과> 간암,바이러스성 간염,지방간,기타 간질환

진료시간표

인터넷진료예약 ...
의사시간표
진료시간
오전 암병원 암병원 암병원
오후 본관 본관

교육 및 임상 경력

  • 1993-1999    연세의대   
  • 1999-2002    공중보건의 
  • 2003-2007    연세대학교    의과대학    전공의 
  • 2008-2010    연세대학교    의과대학    내과학교실    강사 
  • 2011-2012    연세대학교    의과대학    내과학    교실    임상조교수 
  • 2013-2015    연세대학교    의과대학    내과학    교실    조교수 
  • 2016-2019    연세대학교    의과대학    내과학    교실    부교수 
  • 2020-현재    연세대학교    의과대학    내과학    교실    교수

학술관련경력

  • 대한내과학회 회원
  • 대한간학회 회원(2012~2013:홍보위원; 2014~2015:학술위원; 2020~현재: 간행위원장)
  • 대한간암학회 회원 (2014~2015: 학술위원)
  • 대한방사선색전술학회 회원

주요 관심분야

  • 소화기 내과 중에서 간분야가 전문 분야로 만성 B형 또는 C형 간염, 항바이러스 치료,
  • 간경변증의 진단 및 합병증 관리, 간암의 조기 진단 및 치료

학력사항

  • 2004. - 2006. 연세의대 의학대학원 석사
  • 2008. - 2014. 연세의대 의학대학원 박사

논문

  • KH Han, SU Kim (Co-primary). Liver stiffness measurement using FibroScan®. The Korean Journal of Internal Medicine 2008; 74: 463-471.
  • SU Kim. Topics related to liver fibrosis (Summary of AASLD 2009, Boston, USA). The Korean Journal of Hepatology. 2009.
  • SU Kim, KH Han, SH Ahn. Transient elastography in chronic hepatitis B: an Asian perspective. World Journal of Gastroenterology 2010; 16: 5173-5180.
  • KS Jung, SU Kim (Corresponding). Clinical application of transient elastography. Clinical and Molecular Hepatology 2012; 18: 1-10.
  • BY Kim, KH Han, SU Kim (Corresponding). Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from a longitudinal perspective. World Journal of Gastroenterology 2013; 19: 1890-1900.
  • SU Kim, BK Kim, KH Han. Clinical application of liver stiffness measurement using transient elastography: a surgical perspective. Digestion 2013;88:258-265.
  • JH Kim, MN Kim, KH Han, SU Kim (Corresponding). Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment. Liver Int 2015; 35: 1103-1115.
  • ?MS Park, KH Han, SU Kim (Corresponding). Non-invasive prediction of development of hepatocellular carcinoma using transient elastography in patients with chronic liver disease. Expert Rev Gastroenterol Hepatol 2014; 8: 501-511.
  • ? Kim MN, Kim BK, Han KH, Kim SU (Corresponding). Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: consideration for tumor response assessment. Expert Rev Gastroenterol Hepatol 2014; 5: 1-14.
  • ?SM Lim, MJ Chung, KH Han, SU Kim (Corresponding). Acoustic radiation force impulse elastography: a better option for patients with extrahepatic cholestasis. European Journal of Gastroenterology and Hepatology. 2012; 24: 215-216.
  • SM Lim, SU Kim (Corresponding). Acoustic radiation force impulse elastography is useful to exclude nonliver-related ascites. European Journal of Gastroenterology and Hepatology. 2011; 23: 1080-1081.
  • Y Park, SU Kim (Corresponding), MJ Koh, S Lee. Compensated heart failure does not always alleviate overestimation of liver stiffness by transient elastography. European Journal of Gastroenterology and Hepatology 2013; 25: 385-387.
  • ? EH Kim, BK Kim, DY Kim, SU Kim (Corresponding). Optimal timing of combining sorafenib with locoregional treatments in patients with advanced hepatocellular carcinoma. European Journal of Gastroenterology and Hepatology 2013; 25: 514-515.
  • SU Kim, KH Han, SH Ahn. Non-invasive assessment of liver fibrosis: the gap between ideal and real. Journal of Gastroenterology and Hepatology. 2011; 26: 937-939.
  • SU Kim, KH Han, SH Ahn. Non-invasive assessment of liver fibrosis: time to move from cross-sectional studies to longitudinal ones. J Gastroenterology and Hepatology 2010; 25: 1472-1473.
  • V. Leroy, SU Kim (Corresponding). Can transient elastography be used for the management of chronic hepatitis B patients? Liver International. 2012; 32: 528-530.
  • YE Chon, SU Kim, SH Ahn. Transient elastography in real practice: A time for action? Journal of Gastroenterology and Hepatology. 2012; 27: 1134-1135.
  • W Kang, SU Kim (Corresponding). Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD. Clin Mol Hepatol 2013; 19: 255-257.
  • SU Kim, JY Park, WS Kang, DY Kim, YH Paik, KW Lee, BK Kim, BS Kim, YN Park, CY Chon, KH Han, SH Ahn. Liver stiffness measurement in combination with simple non-invasive markers for improved diagnosis of B-viral liver cirrhosis. Journal of Clinical Gastroenterology 2009; 43: 267-271.
  • SU Kim, KH Han, JY Park, SH Ahn, MJ Chung, CY Chon, EH Choi, DY Kim. Liver stiffness measurement using FibroScan® is influenced by serum total bilirubin in acute hepatitis. Liver international 2009; 29: 810-815.
  • DY Kim, SU Kim (Co-primary), SH Ahn, JY Park, JM Lee, YN Park, KT Yoon, YH Paik, KS Lee, CY Chon, KH Han. The usefulness of liver stiffness measurement for the detection of early compensated liver cirrhosis on chronic hepatitis B patients. Digestive Diseases and Sciences 2009; 54: 1758-1763.
  • SU Kim, SH Ahn, JY Park, DY Kim, CY Chon, JS Choi, KS Kim, KH Han. Prediction of postoperative hepatic insufficiency by liver stiffness measurement before curative resection of hepatocellular carcinoma: A pilot study. Hepatology International 2008; 2: 471-477.
  • SU Kim, CM Nam, KH Han, JY Park, DY Kim, BS Moon, CY Chon, YM Moon, SH Ahn. The natural history of HBV-related cirrhotic patients hospitalized to control ascites. Journal of Gastroenterology and Hepatology 2008; 23: 1722-1727.
  • SU Kim, DY Kim, SH Ahn, HJ Nah, CY Chon, KH Han. Hepatocellular carcinoma presenting as bone metastasis. Journal of Cancer Research and Clinical Oncology 2008; 134: 1377-1384.
  • SU Kim, JK Kim, JY Park, SH Ahn, JM Lee, Oidov Baatarkhuu, EH choi, KH Han, CY Chon, DY Kim. Variability of liver stiffness values from different intercostal spaces. Liver International 2009; 28: 760-766.
  • DY Kim, SH Ahn, HW Lee, JY Park, SU Kim, YH Paik, KS Lee, KH Han, CY Chon. Clinical course of virologic breakthrough after emergence of YMDD mutations in HBeAg-positive chronic hepatitis B. Intervirology 2008; 51: 293-298.
  • DY Kim, SH Ahn, HW Lee, SU Kim, JK Kim, YH Paik, KS Lee, KH Han, CY Chon. Anti-hepatitis A virus seroprevalence among patients with chronic viral liver disease in Korea. European Journal of Gastroenterology and Hepatology 2007; 19: 923-926.
  • SU Kim, DY Kim, JY Park, JM Lee, SH Ahn, JK Kim, YH Paik, KS Lee, CY Chon, EH Choi, KJ Song, YN Park, KH Han. How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B. Journal of Clinical Gastroenterology 2010; 44: 66-71.
  • SU Kim, DY Kim, CK Lee, JY Park, SH Kim, HM Kim, EH Choi, S Kim, KH Han, CY Chon. Ascitic fluid infection in patients with hepatitis B virus-related liver cirrhosis: culture-negative neutrocytic ascites versus spontaneous bacterial peritonitis. Journal of Gastroenterology and Hepatology 2010; 25: 122-128.
  • SU Kim, DY Kim, SH Ahn, HM Kim, JM Lee, CY Chon, YN Park, KH Han, JY Park. The impact of steatosis on liver stiffness measurement in patients with chronic hepatitis B. Hepatogastoenterology 2010; 57: 832-838.
  • SU Kim, GH Choi, WK Han, BK Kim, JY Park, DY Kim, JS Choi, SC Yang, EH Choi, SH Ahn, KH Han, CY Chon. What are “true normal” liver stiffness values using FibroScan®?: A prospective study in healthy living liver and kidney donors in South Korea. Liver International 2009; 30: 268-274.
  • SU Kim, JY Park, DY Kim, SH Ahn, EH Choi, JY Seok, JM Lee, YN Park, CY Chon, KH Han. Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: Impact of antiviral treatment on fibrosis regression. Hepatology Int 2010; 4: 673-680.
  • SU Kim, YC Kim, JS Choi, KS Kim, GH Choi, JS Choi, JY Park, DY Kim, SH Ahn, EH Choi, YN Park, CY Chon, KH Han, MJ Kim. Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma?: a pilot study. MRI 2010; 28: 802-811.
  • MJ Chung, JH Cheon, SU Kim, JJ Park, TI Kim, NK Kim, WH Kim. Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behcet disease. J Clin Gastroenterol 2010; 44: e116-122.
  • SU Kim, KH Han, SH Ahn. Transient elastography in chronic hepatitis B: An Asian perspective. World J Gastroenterol 2010; 41: 5173-5180.
  • SU Kim, HW Jang, JY Cheong, JK Kim, MH Lee, DJ Kim, JM Yang, SW Cho, KS Lee, EH Choi, YN Park, KH Han. The usefulness of liver stiffness measurement using FibroScan in chronic hepatitis C in South Korea: A multicenter, prospective study. J Gastroenterol Hepatol 2010, 26: 171-178.
  • SU Kim, YS Seo, JY Cheong, MY Kim, JK Kim, SH Um, SW Cho, SK Paik, KS Lee, KH Han, SH Ahn. Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fiborscan in patients with chronic hepatitis B. Aliment Pharmacol Ther 2010; 32: 498-505.
  • YE Chon, SU Kim (Co-primary), CK Lee, J Heo, JK Kim, KT Yoon, M Cho, KS Lee, DH Kim, EH Choi, JY Park, DY Kim, CY Chon, KH Han, SH Ahn. Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B. Antiviral Ther 2011; 16: 469-477.
  • YE Chon, SU Kim (Co-primary), CK Lee, JY Park, DY Kim, KH Han, CY Chon, SY Kim, KS Jung, SH Ahn. Community-acquired versus nosocominal spontaneous bacterial peritonitis in patients with liver cirrhosis. Hepatogastoenterology 2014; 61: 2283-2290.
  • YE Chon, J Seong, BK Kim, J Cha, SU Kim, JY Park, SH Ahn, KH Han, CY Chon, SK Chin, DY Kim. Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors. Int J Radiat Oncol Biol Phys 2011; 81: 1343-1351.
  • KS Jung, SU Kim (Co-primary), SH Ahn, YN Park, DY Kim, JY Park, CY Chon, EH Choi, KH Han. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan®). Hepatology 2011; 53: 885-894.
  • SH Kim, SB Kim, JG Lee, SU Kim, MS Park, DY Kim, JS Choi, KS Kim. Prognostic factors and 10-year survival in patients with hepatocellular carcinoma after curative hepatectomy. J Gastrointest Surg 2011; 15: 598-607.
  • HW Jang, SU Kim (Co-primary), JY Park, SH Ahn, KH Han, CY Chon, YN Park, EH Choi, DY Kim. How many valid measurements are necessary to assess liver fibrosis using FibroScan® in patients with chronic viral hepatitis? An analysis of subjects with at least 10 valid measurements. Yonsei Medical Journal 2012; 53: 337-345.
  • SU Kim, YE Chon, CK Lee, JY Park, DY Kim, KH Han, CY Chon, S Kim, KS Jung, SH Ahn. Spontaneous bacterial peritonitis in patients with hepatitis B virus-related liver cirrhosis: Community-acquired versus nosocomial Yonsei Medical Journal 2012; 53: 328-336.
  • SJ Byun, SU Kim (Co-primary), JY Park, BK Kim, DY Kim, KH Han, CY Chon, SH Ahn. Acute variceal hemorrhage in patients with liver cirrhosis: Weekend versus weekday admissions. Yonsei Medical Journal 2012; 53: 318-327.
  • KT Yoon, SM Lim, JY Park, DY Kim, SH Ahn, KH Han, CY Chon, M Cho, JW Lee, SU Kim (Corresponding). Liver stiffness measurement using acoustic radiation force impulse (ARFI) elastography and effect of necroinflammation. Digestive and Liver Disease 2012; 57: 1682-1691.
  • YH Chun, SH Ahn, JY Park, DY Kim, KH Han, CY Chon, SJ Byun, SU Kim (Corresponding). Clinical characteristics and treatment outcomes of hepatocellular carcinoma with inferior vena cava/heart invasion. Anticancer Research 2011; 31: 4641-4646.
  • BK Kim, SU Kim (Co-primary), GH Choi, WK Han, MS Park, EH Kim, JY Park, DY Kim, JS Choi, SC Yang, EH Choi, K Song, SH Ahn, KH Han, CY Chon. The “normal” liver stiffness values differ between men and women: A prospective study for healthy living liver and kidney donors in a native Korean population. Journal of Gastroenterology and Hepatology 2012; 27: 781-788.
  • DY Kim, SH Ahn, SU Kim, SB Choi, KH Lee, MS Park, JY Park, DY Lee, KH Han, KS Kim. Adjuvant hepatic arterial infusional chemotherapy with 5-fluorouracil and cisplatin after curative resection of hepatocellular carcinoma. Oncology 2011; 81: 184-191.
  • MH Lee, DY Kim, JK Kim, HY Chang, SH Kang, HJ Ryu, HL Ju, SU Kim, JM Lee, JY Park, KH Han, CY Chon, SH Ahn. Combination of preS deletions and A1762T/F1764A mutations in HBV subgenotype C2 increased the risk of developing HCC. Intervirology 2012; 55: 296-302.
  • YH Chon, SU Kim (Co-primary), JY Park, DY Kim, KH Han, CY Chon, BK Kim, GH Choi, KS Kim, JS Choi, SH Ahn. Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma. European Journal of Cancer 2011; 47: 2568-2575.
  • MH Lee, SU Kim (Co-primary), DY Kim, SH Ahn, EH Choi, KH Lee, DY Lee, J Seong, KH Han, CY Chon, JU Park. Early-on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2012; 27: 313-322.
  • CY Son, SU Kim (Corresponding), WK Han, GH Choi, H Park, SC Yang, JS Choi, JY Park, DY Kim, SH Ahn, CY Chon, KH Han. Normal liver elasticity values using acoustic radiation force impulse imaging: a prospective study in healthy living and kidney donors. Journal of Gastroenterology and Hepatology 2012; 27: 130-136.
  • DY Kim, JW Choi, HY Chang, SU Kim, H Park, YH Paik, JK Kim, SH Ahn, JY Park, SI Chung, KS Lee, KH Han, CY Chon. Toll-like receptor polymorphisms are not associated with liver cirrhosis in hepatitis B virus infected Korean patients. Hepatogastroenterology 2010; 57” 1351-1355.
  • SU Kim, JK Kim, YN Park, KH Han. Discordance between liver biopsy and FibroScan® in assessing liver fibrosis in chronic hepatitis B: risk factors and influence of necroinflammation. PloS One 2012; 7: e32233.
  • YE Chon, GH Choi, MH Lee, SU Kim, DY Kim, SH Ahn, KS Kim, JS Choi, KH Han, CY Chon, JY Park. Combined measurement of preoperative alpha-fetoprotein and des-gamma-carboxyprothrombin predicts recurrence after curative resection in patients with hepatitis-B related hepatocellular carcinoma. International Journal of Cancer 2012; 131: 2332-2341.
  • HS Shin, SU Kim (Co-primary), JY Park, DY Kim, KH Han, CY Chon, Oidov B, SH Ahn. Antiviral efficacy of lamivudine versus entecavir in patients with hepatitis B virus-related advanced hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2012; 27: 1528-1534.
  • BK Kim, SU Kim (Co-primary), JY Park, DY Kim, SH Ahn, J Seong, DY Lee, KH Han. Applicability of BLCL stage for prognostic stratification in comparison with other staging systems; single center experience from long-term clinical outcomes of 1,717 treatment-naive patients with hepatocellular carcinoma. Liver International 2012; 32: 1120-1127.
  • JH Seo, SU Kim (Co-primary), JY Park, DY Kim, KH Han, CY Chon, SH Ahn. Predictors of refractory ascites development in patients with hepatitis B virus-related cirrhosis hospitalized to control ascitic decompensation. Yonsei Medical Journal 2013: 54: 145-153.
  • BK Kim, SU Kim (Co-primary), JY Park, SH Ahn, CY Chon, YN Park, KH Han, DY Kim. Prospective validation of FibroTest in comparison with liver stiffness using transient elastography for predicting liver fibrosis in Asian subjects with chronic hepatitis B. PLos One 2012;7(4):e35825.
  • SU Kim, JH Lee, DY Kim, SH Ahn, KS Jung, EH Choi, YN Park, KH Han, CY Chon, JY Park. Prediction of liver-related events using FibroScan® in chronic hepatitis B patients showing advanced liver fibrosis. PLoS One 2012;7(5):e36676.
  • H Park, SU Kim (Co-primary), DY Kim, SH Ahn, KH Han, CY Chon, JY Park. Optimal time for restoring the reliability of liver stiffness measurement in patients with chronic hepatitis B experiencing acute exacerbation. Journal of Clinical Gastroenterology 2012; 46: 602-607.
  • SU Kim, HJ Oh, Ian RW, S Lee, KH Han, YN Park. Histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis. Journal of Hepatology 2012; 57: 556-563.
  • SH Kang, DY Kim, SM Jeon, SH Ahn, JY Park, SU Kim, JK Kim, KS Lee, CY Chon, KH Han. Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels. European Journal of Gastroenterology and Hepatology 2012; 24: 849-856.
  • YE Chon, ES Jung, JY Park, DY Kim, SH Ahn, KH Han, CY Chon, KS Jung, SU Kim (Corresponding). The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B. Journal of Clinical Gastroenterology. 2012; 46: 518-525.
  • KS Jung, SU Kim (Co-primary), GH Choi, JY Park, YN Park, DY Kim, SH Ahn, CY Chon, KS Kim, EH Choi, JS Choi, KH Han. Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan®). Ann Surg Oncol 2012; 19: 4278-4286.
  • Kim BK, Kim HS, Park JY, Kim do Y, Ahn SH, Chon CY, Han KH, SU Kim (Corresponding). Prospective validation of ELF test in comparison with FibroScan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B. PLoS One 2012; 7: e41964
  • Kim BK, Kim KA, Park JY, Ahn SH, Chon CY, Han KH, Kim SU (Co-corresponding), Kim MJ. Prospective comparison of prognostic values of modified Response Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolization. Eur J Cancer 2013; 49: 826-834.
  • Chon YE, Choi EH, Song KJ, Park JY, Kim DY, Han KH, Chon CY, Ahn SH, Kim SU (Co-corresponding). Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: A meta-analysis. PLoS One 2012; 7: e44930.
  • MS Park, SU Kim (Co-primary), JY Park, DY Kim, SH Ahn, KH Han, CY Chon, J Seong. Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis. Cancer Chemother Pharmacol 2013; 71: 165-173.
  • SW Lee, HJ Park, BK Kim, KH Han, SK Lee, SU Kim (Co-corresponding), YB Park. Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate. Arthritis Res Ther 2012; 14: R232.
  • Kim BK, Kim SU (Corresponding),.Kim MJ, Kim KA, Kim DY, Par JY, Ahn SH, Han KH, Chon CY. Number of target lesions for EASL and modified RECIST to predict survivals in hepatocellular carcinoma treated with chemoembolization. Clin Cancer Res 2013; 19: 1503-11.
  • YK Lee, SU Kim (Co-primary), DY Kim, SH Ahn, KH Lee, DY Lee, KH Han, CY Chon, JY Park. Prognostic value of alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization. BMC cancer 2013; 13: 5.
  • SH Han, SU Kim (Co-primary), CO Kim, SJ Jeong, JY Park, JY Choi, DY Kim, SH Ahn, YG Song, KH Han, JM Kim. Abnormal liver stiffness assessed using transient elastography (FibroScan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment. PLoS One 2013; 8(1): e52720.
  • BK Kim, HJ Oh, JY Park, DY Kim, SH Ahn, KH Han, Y Park, YN Park, SU Kim (Corresponding). Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy. Liver Int. 2013; 32: 180-189.
  • MS Park, BK Kim, JY Cheong, DJ Kim, JY Park, DY Kim, SH Ahn, KH Han, CY Chon, SU Kim (Corresponding). Discordance between liver biopsy and FibroTest in assessing liver fibrosis in chronic hepatitis B. PLoS One. 2013; 8(2): e55759.
  • H Park, JY Park, DY Kim, SH Ahn, CY Chon, KH Han, SU Kim (Corresponding). Characterization of focal liver masses using acoustic radiation force impulse elastography. World J Gastroenterol 2013; 19: 219-226.
  • Y Park, SU Kim (Corresponding), MJ Koh, S Lee. Compensated heart failure does not always alleviate overestimation of liver stiffness by transient elastography. Eur J Gastroenterol 2013; 25: 385-2873
  • EJ Yoo, BK Kim, SU Kim (Corresponding), JY Park, DY Kim, SH Ahn, KH Han, CY Chon, HS Kim. Normal enhanced liver fibrosis (ELF) values in apparently healthy subjects undergoing a health check-up and in in living liver donors in South Korea. Liver Int; 2013; 33: 706-713.
  • MS Park, BK Kim, KS Kim, JK Kim, SU Kim, JY Park, DY Kim, O Baartarkhuu, KH Han, CY Chon. Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B. Clin Mol Hepatol. 2013; 19: 29-35.
  • JY Jang, MY Kim, SW Jeong, TY Kim, SU Kim, SH Lee, KT Suk, SY Park, HY Woo, SG Kim, J Heo, SK Baik, HS Kim, WY Tak. Current consensus and guideline of contrast enhanced ultrasound for the characterization of focal liver lesions. Clin Mol Hepatol. 3013; 19: 1-16.
  • DH Han, GH Choi, KS Kim, JS Choi, YN Park, SU Kim, JY Park, SH Ahn, KH Han. The prognostic significance of the worst grade in hepatocellular carcinoma with heterogeneous histologic grades of differentiation. J Gastroenterol Hepatol. 2013; 28: 1384-90.
  • SH Choi, GH Choi, SU Kim, JU Park, DJ Joo, MK Ju, MS Kim, JS Choi. KH Han. SI Kim. Role of surgical resection for multiple hepatocellular carcinomas. World J Gastoenterol. 2013; 21: 366-374.
  • KH Han, DY Kim, JY Park, SH Ahn, J Kim, SU Kim, JK Kim, KS Lee, CY Chon. Survival of hepatocellular carcinoma patients may be improved in surveillance interval nor more than 6 months compared with more than 6 months: A 15-year prospective study. J Clin Gastroenterol 2013; 47:538-44.
  • SH Kim, DY Kim, JK Lim, SU Kim, CH Choi, SH Ahn, JS Choi, KS Kim. Role of splenectomy in patients with hepatocellular carcinoma and hypersplenism. ANZ J Surg 2013; 83: 865-70.
  • YE Chon, JY Park, SH Ahn, DY Kim, HK Han, CY Chon, A Choi, SU Kim (Corresponding). Partial virological response to adefovir add-on lamivudine rescue therapy in patients with lamivudine-resistant chronic hepatitis B. Digestion 2013; 87: 196-203.
  • DY Kim, HY Chang, SM Lim, SU Kim, JY Park, JK Kim, KS Lee, KH Han, CY Chon, SH Ahn. Quasispecies and pre-existing drug-resistant mutations of hepatitis B virus in patients with chronic hepatitis B. Gut Liver 2013; 7: 329-334.
  • MN Kim, SU Kim (Co-primary), JY Park, DY Kim, KH Han, CY Chon, SH Ahn. Risk assessment of liver-related events using transient elastography in patients with chronic hepatitis B receiving entecavir. J Clin Gastoenterol 2014;48:272-278.
  • EJ Yoo, HS Shin, SU Kim (Corresponding), DJ Joo, JY Park, GH Choi, DY Kim, SH Ahn, J Soeng, MJ Koh, KH Han, CY Chon. Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma. Onco Targets Ther 2013; 6: 755-759.
  • YE Chon, KS Jung, SU Kim (Co-corresponding), JY Park, YN Park, DY Kim, SH Ahn, CY Chon, HW Lee, Y Park, KH Han. Controlled attenuation parameter (CAP for detection of hepatic steatosis in patients with chronic liver disease: a prospective study of a native Korean population. Liver Int 2014;34:102-109.
  • H Park, SU Kim, JU Park, DY Kim, SH Ahn, CY Chon, KH Han, J Seong. Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma. Liver Int 2014; 34: 313-21.
  • SU Kim (Co-primary), KJ Song, HY Chang, EC Shin, JY Park, DY Kim, KH Han, CY Chon, SH Ahn. Association between IL28B polymorphisms and spontaneous clearance of hepatitis B virus infection. PLoS One 2013; 17; 8(7):e69166.
  • DY Kim, KJ Song, SU Kim (Corresponding), EJ Yoo, JY Park, SH Ahn, KH Han. Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model. Onco Targets Ther. 2013; 6: 1463-1469.
  • S Lee, BK Kim, SU Kim (Corresponding), Y Park, S Chang, JY Park, DY Kim, SH Ahn, HK Han. Efficacy of sorafenib monotherapy versus sorafenib-based loco-regional treatments in advanced hepatocellular carcinoma. PLoS One. 2013; 8: e77240.
  • W Kang, SU Kim (Corresponding). Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD. Clin Mol Hepatol 2013; 19: 255-257.
  • JY Jang, MY Kim, SW Jeong, TY Kim, SU Kim, SH Kim, SH Lee, KT Suk, SY Park, HY Woo, SG Kim, J Heo, SK Baik, HS Kim, WY Tak. Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions. Clin Mol Hepaol 2013; 19: 1-16.
  • YE Chon, SU Kim (Co-primary), JY Park, DY Kim, SH Ahn, KH Han, CY Chon, S Lee. Dynamics of the liver stiffness value using transient elastography during the perioperative period in patients with valvular heart disease. PLoS One 2014 26;9:e92795.
  • W Kang, SU Kim (Co-primary), SH Ahn. Non-invasive prediction of forthcoming cirrhosis-related complications. World J Gastroenterol 2014;20:2513-2623.
  • SU Kim (Co-primary), Jung KS, Lee S, Park JY, Kim DY, Ahn SH, Choi GH, Kim KS, Choi JS, Han KH, Park YN. Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma. Liver Int 2014; 34: 1008-17.
  • MN Kim, SU Kim (Corresponding), BK Kim, JY Park, DY Kim, SH Ahn, KH Han. Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir. Liver Int 2014; 34: 1216-23.
  • Shin SH, Kim SU (Co-first), Park JY, Kim DY, Ahn SH, Han KH, Kim BK. Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection; comparison with histological fibrosis. Liver Int 2014; 35: 1054-62.
  • Jung KS, Kim JH, Kim SU (Corresponding), Song K, Kim BK, Park JY, Kim DY, Ahn SH, Moon DC, Song IJ, Choi GH, Park YN, Han KH. Liver stiffness value-based risk estimation of late recurrence after curative resection of hepatocellular carcinoma: development and validation of a predictive model. PLoS One 2014;9:e99167.
  • Jung KS, Kim BK, Kim SU (Corresponding), Chon YE, Cheon KH, Kim SB, Lee SH, Ahn SS, Park JY, Kim DY, Ahn SH, Park YN, Han KH. Factors affecting the accuracy of controlled attenuation parameter (CAP) in assessing hepatic steatosis in patients with chronic liver disease. PLoS One 2014;9:e98689.
  • Yoo BW, Choi JY, Eun LY, Park HK, Park YH, Kim SU (Co-corresponding). Congestive hepatopathy after Fontan operation and related factors assessed by transient elastography. J Thorac Cardiovasc Surg 2014; 148: 1498-505.
  • Kim BK, Kim HS, Yoo EJ, Park JY, Kim DY, Ahn SH, Han KH, Park YN, Kim SU (Co-corresponding). Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test. Hepatology 2014; 60: 1911-9.
  • Chon YE, Jung KS, Kim KJ, Joo DJ, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kim SU (Corresponding). Normal controlled attenuation parameter value: A prospective study of healthy subjects undergoing health checkups and liver donors in Korea. Dig Dis Sci 2015; 60: 234-42.
  • HW Lee, EJ Yoo, BK Kim, SU Kim (Co-corresponding), JY Park, DY Kim, SH Ahn, KH Han. Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy. Am J Gastoenterol 2014; 109: 1241-9.
  • S Lee, BK Kim, SU Kim (Co-corresponding), SY Park, JK Kim, HW Lee, JY Park, DY Kim, SH Ahn, WY Tak, YO Kweon, JI Lee, KS Lee, JH Kim, KH Han. Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: A Korean multicenter study. J Gastroenterol Hepatol 2014; 29: 1463-1469.
  • Lee SH, Kim SU (Co-corresponding), Jang JW, Bae SH, Lee S, Kim BK, Park JY, Kim DY, Ahn SH, Han KH. Use of transient elatography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma. Onco Targets Ther 2015; 8: 437-356.
  • Kim MN, Kim SU (Co-corresponding), Kim BK, Park JY, Kim DY, Ahn SH, Song KJ, Park YN, Han KH. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis. Hepatology 2015 2015; 61: 1851-1959.
  • Kim BK, Kim SU (Corresponding), Kim KA, Chung YE, Kim MJ, Park MS, Park JY, Kim DY, Ahn SH, Kim MD, Park SI, Won JY, Lee DY, Han KH. Complete response at the first chemoembolization is still the robust predictor for favorable outcome in hepatocellular carcinoma. J Hepatol 2015 2015; 62: 1304-1310.
  • Yoo SC, Kim KJ, Kim SU (Corresponding), Kim BK, Park JY, Kim DY, Ahn SH, Lee WJ, Han KH. Factors associated with significant liver fibrosis assessed using transient elastography in general population. World J Gastroenterol 2015; 21: 1158-1166.
  • Wong WV, Lampertico P, de Ledinghen V, Chang PE, Kim SU, Chen Y, Chan HL, Mangia G, Foucher K, Chow WC, Ahn SH, Hou J. Probability-based interpretation of liver stiffness measurement in untreated chronic hepatitis B patients. Dig Dis Sci. 2015; 60: 1448-1456.
  • Kim BK, Kim KA, Ahn C, Yoo EJ, Park JY, Kim DY, Ahn SH, Han KH, Kim SU (Co-corresponding), Kim MJ. Prognostic role of magnetic resonance imaging vs. computed tomography for hepatocellular carcinoma undergoing chemoembolization. Liver Int 2015; 35: 1722-1730.
  • Park MS, Kim SU (Co-primary), Kim BK, Park JY, Kim DY, Ahn SH, Shin SH, Kang W, Moon C, Han KH. Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B. Liver Int 2015; 35: 455-462.
  • Chon YE, Kim SU (co-primary), Lee CK, Park JY, Kim DY, Han KH, Chon JY, Kim S, Jung KS, Ahn SH. Community-acquired vs. nosocomial spontaneous bacterial peritonitis in patients with liver cirrhosis. Hepatogastroenteroloy. 2015; 61: 2283-2290.
  • Park Y, Kim SU (Co-corresponding), Park SY, Kim BK, Park JY, Kim DY, Ahn SH, Tak WY, Kweon YO, Han KH. A novel model to predict esophageal varices in patients with compensated cirrhosis using acoustic radiation force impulse elastography. PLoS One 31:10:e0101009.
  • Lee YH, Jung KS, Kim SU, Yoon HJ, Yun YJ, Lee BW, Kang ES, Han KH, Cha BS. Sarcopenia is associated with NAFLD independently of obesity and insulin resistance: nationwide surveys (KNHANES 2008-2011). J Hepatol [in press]
  • Ahn SS, Kim EH, Kim MD, Lee WJ, Kim SU (Corresponding). Successful hemostasis of intractable rectal variceal bleeding using variceal embolization. World J Gastroenterol 21; 21: 2558-2562.
  • Seo YS, Kim MY, Kim SU (co-corresponding), Hyun BS, Jang JY, Lee JW, Lee JI, Suh SJ, Park SY, Park H, Jung EU, Kim BS, Kim IH, Lee TH, Um SH, Han KH, Kim SG, Paik SK, Choi JY, Jeong SW, Jin YJ, Lee KS, Yim HJ, Tak WY, Hwang SG, Lee YJ, Lee CH, Kim DG, Kang YW, Kim YS: The Korean Transient Elastography Study Group. Liver Int [in press].
  • Park MS, Kim SW, Yoon KT, Kim SU, Park SY, Tak WY, Kweon YO, Cho M, Kim BK, Park JY, Kim DY, Ahn SH, Han KH. Factors influencing the diagnostic accuracy of acoustic radiation force impulse elastography in patients with chronic hepatitis B. Gut Liver [in press]
  • Park Y, Kim SU (Corresponding), Kim BK, Park JY, Kim DY, Ahn SH, Park YE, Park JH, Lee YI, Yun HR, Han KH. Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial-embolization prognostic score. Liver Int [in press].
  • Kim MN, Han KH, Kim SU (Corresponding). Reply to “Patients with chronic hepatitis b should be screened for hepatocellular carcinoma regardless of liver stiffness measurement.” Hepatology [in press].
  • Kim BK, Kim KA, Kim MJ, Park JY, Kim DY, Ahn SH, Han KH, Kim SU (Co-corresponding), Park MS. Inter-observer variability of response evaluation criteria for hepatocellular carcinoma treated with chemoembolization. Dig Liver Dis. [in press]
  • You SC, Kim KJ, Kim SU (Co-corresponding), Kim BK, Park JY, Kim DY, Ahn SH, Han KH. Hepatic fibrosis assessed using transient elastography in independently associated with coronary artery calcification. J Gastroenterol Hepatol [in press]
  • Lee HW, Kang W, Kim BK, Kim SU (Corresponding), Park JY, Kim DY, Ahn SH, Park YN, Han KH. Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B. Liver Int [in press].
  • Kim BK, Shim JH, Kim SU (Co-corresponding), Park JY, Kim DY, Ahn SH, Kim KM, Lim YS, Han KH, Lee HC. Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction model. Liver Int [in press].
  • Kim BK, Kim SU (Corresponding). Reply to ‘The problem of the most appropriate curative treatment for hepatocellular carcinoma. When to embolize? When to operate?”. J Hepatol 2015; 63: 281-282.
  • Lee YH, Kim SU (Corresponding), Song K, Park JY, Kim DY, Ahn SH, Lee BW, Kang ES, Cha BS, Han KH. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011). Hepatology [in press].
  • Lee SW, Kim BK, Park JY, Kim DY, Ahn SH, Song J, Park YB, Lee SK, Han KH, Kim SU (Corresponding). Clinical predictors of silent but substantial liver fibrosis in primary Sjogren’s syndrome. Mod Rheumatol [in press].
  • Lee S, Park JY, Kim DY, Kim BK, Kim SU, Song K, Ku HJ, Han KH, Ahn SH. Prediction of virologic response to tenofovir mono-therapy for multidrug resistant chronic hepatitis B. J Med Virol [in press].
  • Lee S, Kim BK, Song K, Park JY, Ahn SH, Kim SU, Han KH. Sub-classification of Barcelona Clinic Liver Cancer B and C hepatocellular carcinoma: A cohort study of the multi-center registry database. J Gastroenterol Hepatol [in press].
  • Choi SH, Park JY, Kang W, Kim SU, Kim DY, Ahn SH, Ro SW, Han KH. Knockdown of HIF-1α and IL-8 induced apoptosis of hepatocellular carcinoma triggers apoptosis of vascular endothelial cells. Apoptosis [in press].
  • Chung H, Chon YE, Kim SU (Co-corresponding), Lee SK, Jung KS, Han KH, Chon CY. Noninvasive prediction of erosive esophagitis using a controlled attenuation parameter (CAP)-based risk estimation model. Dig Dis Sci [in press].
  • Lee J, Oh YT, Joo DJ, Ma BG, Lee AL, Lee JG, Song SH, Kim SU, Jung DC, Chung YE, Kim YS. Acoustic radiation force impulse measurement in renal transplantation: A prospective, longitudinal study with protocol biopsies. Medicine (Baltimore) [in press].
  • Kim YD, Song D, Heo JH, Kim SU (Co-corresponding), Kim BK, Park JY, Kim DY, Ahn SH, Kim KJ, Han KH. Relationship between cerebral microbleeds and liver stiffness determined by transient elastography. PLoS One 2015; 30;10(9):e0139227.
  • Lee HW, Chon YE, Kim SU (Co-corresponding), Kim BK, Park JY, Kim DY, Ahn SH, Jung KS, Park YN, Han KH. Predicting liver-related events using transient elastography in chronic hepatitis C patients with sustained virological response. Gut Liver 2015 [in press].
  • Lim TS, Kim DY, Han KH, Kim HS, Shin SH, Jung KS, Kim BK, Kim SU, Park JY, Ahn SH. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients. Scand J Gastroenterol 2016; 51: 344-353.
  • Kim SU, Park JH, Kim HS, Lee JM, Lee HG, Kim H, Choi SH, Baek S, Kim BK, Park JY, Kim DY, Ahn SH, Lee JD, Han KH. Serum Dickkopf-1 as a biomarker for the diagnosis of hepatocellular carcinoma. Yonsei Med J. 2015; 56: 1296-1306.
  • Jung KS, Kim SU, Song K, Park JY, Kim DY, Ahn SH, Kim BK, Han KH. Validation of hepatitis B virus-related hepatocellular carcinoma prediction models in the era of antiviral therapy. Hepatology [in press].
  • Lee SW, Kim BK, Park JY, Kim DY, Ahn SH, Song JJ, Park YB, Lee SK, Han KH, Kim SU (Corresponding). Disease duration and Medsger’s severity score are associated with significant liver fibrosis in patients with systemic sclerosis. Clin Exp Rheumatol 2015; 33: S68-74.
  • Kim SB, Kim SU (Corresponding), Kim BK, Park JY, Kim DY, Ahn SH, Han KH. Outcome of adefovir add-on lamivudine rescue therapy of up to 5 years in patients with lamivudine-resistant chronic hepatitis B. J Gastroenterol Hepatol 2015 [in press].
  • Park Y, Kim SU (Corresponding). Reply to ‘prognostic model for patients receiving arterial-embolization for hepatocellular carcinoma: issues to consider’. Liver Int [in press].
  • SU Kim, YR Kim, DY Kim, JK Kim, HW Lee, BK Kim, YH Paik, KS Lee, KH Han, CY Chon, YM Moon, SH Ahn. The clinical features and treatment outcome of advanced hepatocellular carcinoma with inferior vena caval invasion or atrial tumor thrombus. The Korean Journal of Hepatology 2007; 13: 387-395.
  • HJ Choi, SY Ko, WH Choe, YS Seo, JK Kim, KS Byun, YS Kima, SU Kim, SK Baik, JY Cheong, TY Kim, OS Kwon, JH Kim, CH Lee, SY Kwon. Clinical features of acute viral hepatitis B in Korea: a multi-center study. Korean J Hepatol 2011; 17: 307-3012.
  • Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 54/10 :1,283-1,290,2019
  • Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
    Clinical and molecular hepatology 25/3 :283-293,2019
  • External validation of the modified PAGE-B score in Asian chronic hepatitis B patients receiving antiviral therapy
    LIVER INTERNATIONAL 39/9 :1,624-1,630,2019
  • Staged partial hepatectomy versus transarterial chemoembolization for the treatment of spontaneous hepatocellular carcinoma rupture: a multicenter analysis in Korea
    ANNALS OF SURGICAL TREATMENT AND RESEARCH 96/6 :275-282,2019
  • Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
    CANCER MEDICINE 8/11 :5,023-5,032,2019
  • A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naive chronic hepatitis B in South Korea
    JOURNAL OF HEPATOLOGY 71/3 :456-464,2019
  • A Lesion-Based Convolutional Neural Network Improves Endoscopic Detection and Depth Prediction of Early Gastric Cancer.
    Journal of Clinical Medicine 8/9 :E1310.-,2019
  • Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY 30/8 :1,194-1,200,2019
  • Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    Cancers 11/4 :E509-,2019
  • Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals
    Clinical and Translational Gastroenterology 10/6 :e00036-,2019
  • Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status
    GUT AND LIVER 13/2 :197-205,2019
  • Multicenter Retrospective Risk Assessment of Esophageal Variceal Bleeding in Patients with Cirrhosis: An Acoustic Radiation Force Impulse Elastography-Based Prediction Model
    GUT AND LIVER 13/2 :206-214,2019
  • Noninvasive monitoring of hepatic steatosis: controlled attenuation parameter and magnetic resonance imaging-proton density fat fraction in patients with nonalcoholic fatty liver disease
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY 13/6 :523-530,2019
  • Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease
    LIVER INTERNATIONAL 39/6 :1071-1079,2019
  • Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma
    BMC CANCER 19/363 :-,2019
  • Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
    PLOS ONE 14/4 :e0214613-,2019
  • Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis
    Journal of Clinical Medicine 7/8 :3-,2019
  • Optimal criteria for hepatocellular carcinoma diagnosis using CT in patients undergoing liver transplantation
    EUROPEAN RADIOLOGY 29/2 :1,022-1,031,2019
  • The Paradoxical Protective Effect of Liver Steatosis on Severity and Functional Outcome of Ischemic Stroke
    FRONTIERS IN NEUROLOGY 10/375 :1-7,2019
  • Follow-Up Liver Stiffness Measurements after Liver Resection Influence Oncologic Outcomes of Hepatitis-B-Associated Hepatocellular Carcinoma with Liver Cirrhosis
    Cancers 11/3 : E425-,2019
  • Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
    SCIENTIFIC REPORTS 9/1 :2,508-,2019
  • Fibrosis-matched outcomes between chronic hepatitis B patients with drug-induced virological response and inactive carriers
    LIVER INTERNATIONAL 39/1 :81-89,2019
  • Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients
    CEREBROVASCULAR DISEASES 47/1-2 :32-39,2019
  • Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
    CANCER CHEMOTHERAPY AND PHARMACOLOGY 82/3 :469-478,2018
  • Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib
    LIVER INTERNATIONAL 38/9 :1,655-1,663,2018
  • Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS 48/3 :300-312,2018
  • Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B
    LIVER INTERNATIONAL 38/4 :676-686,2018
  • Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety
    GUT AND LIVER 12/3 :324-330,2018
  • Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS 47/8 :1,201-1,212,2018
  • Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance
    JOURNAL OF MEDICAL VIROLOGY 90/3 :497-502,2018
  • Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B
    GUT AND LIVER 12/2 :190-200,2018
  • Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus?related advanced fibrosis or cirrhosis
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 33/2 :503-510,2018
  • Validation of risk prediction models for the development of HBV-related HCC: A retrospective multi-center 10-year followup cohort study
    ONCOTARGET 8/68 :113,213-113,224,2017
  • Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease
    DIGESTIVE DISEASES AND SCIENCES 62/8 :2,150-2,158,2017
  • Validation of the PAGE-B Model in Asian Chronic Hepatitis B Patients Receiving Entecavir or Tenofovir
    LIVER INTERNATIONAL 37/12 :1788-1795,2017
  • Survival Estimates after Stopping Sorafenib in Patients with Hepatocellular Carcinoma: NEXT Score Development and Validation
    GUT AND LIVER 11/5 :693-701,2017
  • Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
    GUT AND LIVER 11/6 :828-834,2017
  • Can Magnetic Resonance Elastography Fill a Niche in the Market for Noninvasive Assessment of Liver Fibrosis?
    GUT AND LIVER 11/3 :321-322,2017
  • Dickkopf-1 induces angiogenesis via VEGF receptor 2 regulation independent of the Wnt signaling pathway
    ONCOTARGET 8/35 :58,974-58,984,2017
  • Conditional survival estimate in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy with/without concurrent radiotherapy
    ONCOTARGET 8/45 :79,914-79,926,2017
  • Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development
    LIVER INTERNATIONAL 37/6 :879-887,2017
  • Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 99/2 :396-406,2017
  • Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 32/8 :1,487-1,494,2017
  • Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 32/5 :1,079-1,086,2017
  • Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 32/6 :1,221-1,229,2017
  • Liver fibrosis assessed with transient elastography is an independent risk factor for ischemic stroke
    ATHEROSCLEROSIS 260/ :156-162,2017
  • Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis
    HEPATOLOGY INTERNATIONAL 11/3 :268-276,2017
  • Fatty liver associated with metabolic derangement in patients with chronic kidney disease: A controlled attenuation parameter study.
    Kidney Research and Clinical Practice 36/1 :48-57,2017
  • Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis
    AMERICAN JOURNAL OF GASTROENTEROLOGY 112/6 :882-891,2017
  • Bariatric Arterial Embolization with Non-spherical Polyvinyl Alcohol Particles for Ghrelin Suppression in a Swine Model
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY 40/5 :744-749,2017
  • Prognostic factors of sorafenib therapy in hepatocellular carcinoma patients with failure of transarterial chemoembolization
    HEPATOLOGY INTERNATIONAL 11/3 :292-299,2017
  • The LAW index as an accurate indicator of the initiation of antiviral treatment in patients with chronic hepatitis B
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 32/1 :208-214,2017
  • Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: Comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study
    ACTA RADIOLOGICA 58/2 :131-139,2017
  • Conventional versus drug-eluting beads chemoembolization for hpeatocellular carcinoma: Emphasis on the impact of tumor size
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 32/2 :487-496,2017
  • Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance
    JOURNAL OF VIRAL HEPATITIS 24/2 :141-147,2017
  • Durability of the virological response after lamivudine discontinuation in lamivudine-resistant patients with a complete virological response after lamivudine and adefovir combination therapy
    JOURNAL OF MEDICAL VIROLOGY 89/1 :85-90,2017
  • Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status
    METABOLISM-CLINICAL AND EXPERIMENTAL 66/ :23-31,2017
  • Knockdown of HIF-1 alpha and IL-8 induced apoptosis of hepatocellular carcinoma triggers apoptosis of vascular endothelial cells
    APOPTOSIS 21/1 :85-95,2016
  • Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 14/11 :1,647-1,647,2016
  • Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis C
    JOURNAL OF KOREAN MEDICAL SCIENCE 31/9 :1,431-1,437,2016
  • Prognostic significance of 18F-FDG uptake in hepatocellular carcinoma treated with transarterial chemoembolization or concurrent chemoradiotherapy: A multicenter retrospective cohort study
    JOURNAL OF NUCLEAR MEDICINE 57/4 :509-516,2016
  • Cryoablation of Hepatocellular Carcinoma with High-Risk for Percutaneous Ablation: Safety and Efficacy
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY 39/10 :1447-1454,2016
  • Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma
    ONCOTARGET 7/27 :41718-41810,2016
  • Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease
    PLOS ONE 11/6 :e0157358-,2016
  • Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients
    JOURNAL OF GASTROENTEROLOGY 51/8 :830-839,2016
  • Incidence and risk factors of delayed postpolypectomy bleeding in patients with chronic liver disease
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 51/5 :618-624,2016
  • The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter
    YONSEI MEDICAL JOURNAL 57/4 :885-892,2016
  • Clinical predictors of silent but substantial liver fibrosis in primary Sjogren's syndrome.
    MODERN RHEUMATOLOGY 26/4 :576-582,2016
  • Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
    MEDICINE 95/20 :e3434-,2016
  • Subclassification of Barcelona Clinic Liver Cancer B and C hepatocellular carcinoma: A cohort study of the multicenter registry database
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 31/4 :842-847,2016
  • Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response
    GUT AND LIVER 10/3 :429-436,2016
  • Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus
    MEDICINE 95/14 :e3328-,2016
  • Prediction of Virologic Response to Tenofovir Mono-Rescue Therapy for Multidrug Resistant Chronic Hepatitis B
    JOURNAL OF MEDICAL VIROLOGY 88/6 :1027-1034,2016
  • Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy.
    MEDICINE 95/12 :e2985-,2016
  • Factors Influencing the Diagnostic Accuracy of Acoustic Radiation Force Impulse Elastography in Patients with Chronic Hepatitis B
    GUT AND LIVER 10/2 :275-282,2016
  • Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction model.
    LIVER INTERNATIONAL 36/1 :92-99,2016
  • Noninvasive Prediction of Erosive Esophagitis Using a Controlled Attenuation Parameter (CAP)-Based Risk Estimation Model.
    DIGESTIVE DISEASES AND SCIENCES 61/2 :507-516,2016
  • Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B
    LIVER INTERNATIONAL 36/1 :24-30,2016
  • Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial-embolization prognostic score
    LIVER INTERNATIONAL 36/1 :100-107,2016
  • Outcome of adefovir add-on lamivudine rescue therapy of up to 5?years in patients with lamivudine-resistant chronic hepatitis B.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 31/1 :241-247,2016
  • Sarcopenia Is Associated With Significant Liver Fibrosis Independently of Obesity and Insulin Resistance in Nonalcoholic Fatty Liver Disease: Nationwide Surveys (KNHANES 2008-2011)
    HEPATOLOGY 63/3 :776-786,2016
  • Knockdown of HIF-1a and IL-8 induced apoptosis of hepatocellular carcinoma triggers apoptosis of vascular endothelial cells
    APOPTOSIS 21/1 :85-95,2016
  • Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 51/3 :344-353,2016
  • Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis
    LIVER INTERNATIONAL 35/3 :1054-1062,2015
  • Validation of Hepatitis B Virus-Related Hepatocellular Carcinoma Prediction Models in the Era of Antiviral Therapy
    HEPATOLOGY 62/6 :1757-1766,2015
  • Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B
    GUT AND LIVER 9/6 :776-783,2015
  • Relationship between Cerebral Microbleeds and Liver Stiffness Determined by Transient Elastography
    PLOS ONE 10/9 :e0139227-,2015
  • Probability-Based Interpretation of Liver Stiffness Measurement in Untreated Chronic Hepatitis B Patients
    DIGESTIVE DISEASES AND SCIENCES 60/5 :1448-1456,2015
  • Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study
    LIVER INTERNATIONAL 35/10 :2246-2255,2015
  • Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma
    YONSEI MEDICAL JOURNAL 56/5 :1296-1306,2015
  • Acoustic Radiation Force Impulse Measurement in Renal Transplantation: A Prospective, Longitudinal Study With Protocol Biopsies
    MEDICINE 94/39 :e1590-,2015
  • Hepatic fibrosis assessed using transient elastography independently associated with coronary artery calcification
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 30/10 :1536-1542,2015
  • Disease duration and Medsger’s severity score are associated with significant liver fibrosis in patients with systemic sclerosis
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Suppl. 91 :S68-S74,2015
  • Inter-observer variability of response evaluation criteria for hepatocellular carcinoma treated with chemoembolization
    DIGESTIVE AND LIVER DISEASE 47/8 :682-688,2015
  • Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008?2011)
    JOURNAL OF HEPATOLOGY 63/2 :486-493,2015
  • Prognostic role of magnetic resonance imaging vs. computed tomography for hepatocellular carcinoma undergoing chemoembolization
    LIVER INTERNATIONAL 35/6 :1722-1730,2015
  • Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma
    JOURNAL OF HEPATOLOGY 62/6 :1304-1310,2015
  • Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients With Transient Elastography-Defined Subclinical Cirrhosis
    HEPATOLOGY 61/6 :1851-1859,2015
  • Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment
    LIVER INTERNATIONAL 35/4 :1103-1115,2015
  • A Novel Model to Predict Esophageal Varices in Patients with Compensated Cirrhosis Using Acoustic Radiation Force Impulse Elastography
    PLOS ONE 10/3 :e0121009-,2015
  • Successful hemostasis of intractable rectal variceal bleeding using variceal embolization
    WORLD JOURNAL OF GASTROENTEROLOGY 21/8 :2558-2562,2015
  • Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B
    LIVER INTERNATIONAL 35/2 :455-462,2015
  • Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea
    DIGESTIVE DISEASES AND SCIENCES 60/1 :234-242,2015
  • Use of transient elastography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma
    ONCOTARGETS AND THERAPY 8/ :347-356,2015
  • Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: Considerations for tumor response assessment
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY 9/3 :335-348,2015
  • Factors associated with significant liver fibrosis assessed using transient elastography in general population
    WORLD JOURNAL OF GASTROENTEROLOGY 21/Issue :1158-1166,2015
  • Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virologic response by pegylated interferon and ribavirin
    DIGESTIVE DISEASES AND SCIENCES 60/2 :573-581,2015
  • Silencing of hypoxia-inducible factor-1β induces anti-tumor effects in hepatoma cell lines under tumor hypoxia.
    PLOS ONE 9/7 :e103304-,2014
  • Inhibition of tumour angiogenesis and growth by small hairpin HIF-1a and IL-8 in hepatocellular carcinoma
    LIVER INTERNATIONAL 34/4 :632-642,2014
  • Maintaining remission in lamivudine-resistant patients with a virological response to adefovir add-on lamivudine after stopping lamivudine therapy
    LIVER INTERNATIONAL 34/10 :1543-1549,2014
  • Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test
    HEPATOLOGY 60/6 :1911-1919,2014
  • Non-invasive prediction of development of hepatocellular carcinoma using transient elastography in patients with chronic liver disease
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY 8/5 :501-511,2014
  • Congestive hepatopathy after Fontan operation and related factors assessed by transient elastography
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY 148/4 :1498-1505,2014
  • Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naive chronic hepatitis B patients in Korea
    Clinical and molecular hepatology 20/3 :261-266,2014
  • Surgical Resection After Down-Staging of Locally Advanced Hepatocellular Carcinoma by Localized Concurrent Chemoradiotherapy
    ANNALS OF SURGICAL ONCOLOGY 21/11 :3646-3653,2014
  • Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: A Korean multicenter study
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 29/7 :1463-1469,2014
  • Prediction of development of liver-related events by transient elastography in Hepatitis B patients with complete virological response on antiviral therapy
    AMERICAN JOURNAL OF GASTROENTEROLOGY 109/8 :1241-1249,2014
  • Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir
    LIVER INTERNATIONAL 34/8 :1216-1223,2014
  • Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma
    LIVER INTERNATIONAL 34/7 :1008-1017,2014
  • Impact of Spontaneous Hepatocellular Carcinoma Rupture on Recurrence Pattern and Long-term Surgical Outcomes after Partial Hepatectomy
    WORLD JOURNAL OF SURGERY 38/8 :2070-2078,2014
  • Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 29/5 :1005-1011,2014
  • Liver Stiffness Value-Based Risk Estimation of Late Recurrence after Curative Resection of Hepatocellular Carcinoma: Development and Validation of a Predictive Model
    PLOS ONE 9/6 :e99167-,2014
  • Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease
    PLOS ONE 9/6 :e98689-,2014
  • Prognosis of hepatocellular carcinoma patients with extrahepatic metastasis and the controllability of intrahepatic lesions
    CLINICAL & EXPERIMENTAL METASTASIS 31/4 :475-482,2014
  • Dynamics of the Liver Stiffness Value Using Transient Elastography during the Perioperative Period in Patients with Valvular Heart Disease
    PLOS ONE 9/Issue 3 :e92795-,2014
  • Non-invasive prediction of forthcoming cirrhosis-related complications
    WORLD JOURNAL OF GASTROENTEROLOGY 20/10 :2613-2623,2014
  • Risk Assessment of Liver-related Events Using Transient Elastography in Patients With Chronic Hepatitis B Receiving Entecavir
    JOURNAL OF CLINICAL GASTROENTEROLOGY 48/3 :272-278,2014
  • Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma
    LIVER INTERNATIONAL 34/2 :313-321,2014
  • Use of the Delta Neutrophil Index as a Prognostic Factor of Mortality in Patients with Spontaneous Bacterial Peritonitis: Implications of a Simple and Useful Marker
    PLOS ONE 9/1 :e86884-,2014
  • Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population
    LIVER INTERNATIONAL 34/1 :102-109,2014
  • Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir
    WORLD JOURNAL OF GASTROENTEROLOGY 19/43 :7,671-7,679,2013
  • Quasispecies and Pre-Existing Drug-Resistant Mutations of Hepatitis B Virus in Patients with Chronic Hepatitis B
    GUT AND LIVER 7/3 :329-334,2013
  • Survival of Hepatocellular Carcinoma Patients May be Improved in Surveillance Interval not More Than 6 Months Compared With More Than 6 Months: A 15-Year Prospective Study
    JOURNAL OF CLINICAL GASTROENTEROLOGY 47/6 :538-544,2013
  • Abnormal Liver Stiffness Assessed Using Transient Elastography (Fibroscan (R)) in HIV-Infected Patients without HBV/HCV Coinfection Receiving Combined Antiretroviral Treatment
    PLOS ONE 8/1 :e52720-e52727,2013
  • Predictors of Refractory Ascites Development in Patients with Hepatitis B Virus-Related Cirrhosis Hospitalized to Control Ascitic Decompensation
    YONSEI MEDICAL JOURNAL 54/ :145-153,2013
  • Predictors of Refractory Ascites Development in Patients with Hepatitis B Virus-Related Cirrhosis Hospitalized to Control Ascitic Decompensation
    YONSEI MEDICAL JOURNAL 54/1 :145-153,2013
  • Efficary of switching to telbivudine pius adefovir in suboptimal responders to lamivudine plus adefovir
    WORLD JOURNAL OF GASTROENTEROLOGY 19/43 :7671-7679,2013
  • Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B
    Clinical and Molecular Hepatology 19/1 :29-35,2013
  • Graft Function Measured by Transient Elastography in Living Donor Liver Transplantation: Preliminary
    TRANSPLANTATION PROCEEDINGS 45/8 :3028-3031,2013
  • Clinical Application of Liver Stiffness Measurement Using Transient Elastography : A Surgical Perspective
    DIGESTION 88/4 :258-265,2013
  • Role of splenectomy in patients with hepatocellular carcinoma and hypersplenism
    ANZ JOURNAL OF SURGERY 83/11 :865-870,2013
  • Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma
    PLOS ONE 8/10 :e77240-,2013
  • Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model
    ONCOTARGETS AND THERAPY 6/- :1463-1469,2013
  • Prognostic significance of the worst grade in hepatocellular carcinoma with heterogeneous histologic grades of differentiation
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 28/8 :1384-1390,2013
  • Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma
    ONCOTARGETS AND THERAPY 6/ :755-759,2013
  • Association between IL28B Polymorphisms and Spontaneous Clearance of Hepatitis B Virus Infection
    PLOS ONE 8/7 :e69166-e69166,2013
  • Survival of hepatocellular carcinoma patients may be improved in surveillance interval not more than 6 months compared with more than 6 months; A 15-year prospective study
    JOURNAL OF CLINICAL GASTROENTEROLOGY 47/6 :538-544,2013
  • Quasispecies and Pre-Existing Drug-Resistant Mutations of Hepatitis B Virus in Patients with Chronic Hepatitis B
    GUT AND LIVER 7/3 :329-334,2013
  • Partial Virological Response to Adefovir Add-On Lamivudine Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B
    DIGESTION 87/3 :196-203,2013
  • Number of target lesions for EASL and modified RECIST to predict survivals in hepatocellular carcinoma treated with chemoembolization
    CLINICAL CANCER RESEARCH 19/6 :1503-1511,2013
  • Normal enhanced liver fibrosis (ELF) values in apparently healthy subjects undergoing a health check-up and in living liver donors in South Korea
    LIVER INTERNATIONAL 33/5 :706-713,2013
  • Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives
    WORLD JOURNAL OF GASTROENTEROLOGY 19/12 :1890-1900,2013
  • Optimal timing of combining sorafenib with locoregional treatments in patients with advanced hepatocellular carcinoma
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 25/4 :514-515,2013
  • Characterization of focal liver masses using acoustic radiation force impulse elastography
    WORLD JOURNAL OF GASTROENTEROLOGY 19/2 :219-226,2013
  • The use of health functional foods in gastrointestinal cancer patients
    Clinical nutrition research 2/1 :19-25,2013
  • Compensated heart failure does not always alleviate overestimation of liver stiffness by transient elastography
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 25/3 :385-387,2013
  • Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation
    EUROPEAN JOURNAL OF CANCER 49/4 :826-834,2013
  • Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy
    LIVER INTERNATIONAL 33/2 :180-189,2013
  • Discordance between Liver Biopsy and FibroTest in Assessing Liver Fibrosis in Chronic Hepatitis B
    PLOS ONE 8/2 :e55759-e55759,2013
  • Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
    BMC CANCER 13/5 :1-10,2013
  • Role of surgical resection for multiple hepatocellular carcinoma
    WORLD JOURNAL OF GASTROENTEROLOGY 19/3 :366-374,2013
  • Abnormal Liver Stiffness Assessed Using Transient Elastography (Fibroscan) in HIV-Infected Patients without HBV/HCV Coinfection Receiving Combined Antiretroviral Treatment
    PLOS ONE 8/1 :e52720-e52720,2013
  • Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis
    CANCER CHEMOTHERAPY AND PHARMACOLOGY 71/1 :165-173,2013
  • Clinical features and prognosis of hepatocellular carcinoma in Mongolia: a multicentre study
    HEPATOLOGY INTERNATIONAL 6/ :763-769,2012
  • Prediction of Recurrence after Curative Resection of Hepatocellular Carcinoma using Liver Stiffness Measurement (FibroScan ?)
    ANNALS OF SURGICAL ONCOLOGY 19/13 :4278-4286,2012
  • Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate.
    ARTHRITIS RESEARCH & THERAPY 14/5 :R232-,2012
  • The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis
    JOURNAL OF HEPATOLOGY 57/3 :556-563,2012
  • Transient elastography in real practice: A time for action?
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 27/7 :1134-1135,2012
  • Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis
    PLOS ONE 7/9 :e44930-,2012
  • Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma
    INTERNATIONAL JOURNAL OF CANCER 131/10 :2332-2341,2012
  • How Many Valid Measurements Are Necessary to Assess Liver Fibrosis Using FibroScan? in Patients with Chronic Viral Hepatitis? An Analysis of Subjects with at Least 10 Valid Measurements
    YONSEI MEDICAL JOURNAL 53/2 :337-345,2012
  • Can transient elastography be used for the management of chronic hepatitis B patients?
    LIVER INTERNATIONAL 32/4 :528-530,2012
  • Revision and update on clinical practice guideline for liver cirrhosis.
    The Korean Journal of Hepatology 18/1 :1-21,2012
  • Antiviral efficacy of lamivudine versus entecavir in patients with hepatitis B virus-related advanced hepatocellular carcinoma.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 27/9 :1528-1534,2012
  • Liver Stiffness Measurement Using Acoustic Radiation Force Impulse (ARFI) Elastography and Effect of Necroinflammation
    DIGESTIVE DISEASES AND SCIENCES 57/6 :1682-1691,2012
  • Prospective Validation of ELF Test in Comparison with Fibroscan and FibroTest to Predict Liver Fibrosis in Asian Subjects with Chronic Hepatitis B
    PLOS ONE 7/7 :-,2012
  • The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B
    JOURNAL OF CLINICAL GASTROENTEROLOGY 46/6 :518-525,2012
  • Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis
    PLOS ONE 7/5 :e36676-e36676,2012
  • Combination of preS Deletions and A1762T/G1764A Mutations in HBV Subgenotype C2 Increases the Risk of Developing HCC
    INTERVIROLOGY 55/4 :296-302,2012
  • Discordance between Liver Biopsy and FibroScan (R) in Assessing Liver Fibrosis in Chronic Hepatitis B: Risk Factors and Influence of Necroinflammation
    PLOS ONE 7/2 :e32233-e32233,2012
  • Optimal Time for Restoring the Reliability of Liver Stiffness Measurement in Patients With Chronic Hepatitis B Experiencing Acute Exacerbation
    JOURNAL OF CLINICAL GASTROENTEROLOGY 46/ :602-607,2012
  • Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: Single centre experience from long-term clinical outcomes of 1717 treatment-na?ve patients with hepatocellular carcinoma
    LIVER INTERNATIONAL 32/7 :1120-1127,2012
  • "Normal" liver stiffness values differ between men and women: A prospective study for healthy living liver and kidney donors in a native Korean population
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 27/4 :781-788,2012
  • Spontaneous Bacterial Peritonitis in Patients with Hepatitis B Virus-Related Liver Cirrhosis: Community-Acquired versus Nosocomial
    YONSEI MEDICAL JOURNAL 53/2 :328-336,2012
  • Acute Variceal Hemorrhage in Patients with Liver Cirrhosis: Weekend versus Weekday Admissions
    YONSEI MEDICAL JOURNAL 53/2 :318-327,2012
  • Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 24/7 :849-856,2012
  • Prospective validation of Fibrotest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B
    PLOS ONE 7/4 :1-8,2012
  • Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS 35/11 :1343-1350,2012
  • Acoustic radiation force impulse elastography: a better option for patients with extrahepatic cholestasis
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 24/2 :215-216,2012
  • Normal liver elasticity values using acoustic radiation force impulse imaging: A prospective study in healthy living liver and kidney donors
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 27/1 :130-136,2012
  • Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 27/2 :313-322,2012
  • Acoustic radiation force impulse elastography is useful to exclude nonliver-related ascites
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 23/11 :1080-1081,2011
  • Clinical Characteristics and Treatment Outcomes of Hepatocellular Carcinoma with Inferior Vena Cava/Heart Invasion
    ANTICANCER RESEARCH 31/12 :4641-4646,2011
  • Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma
    EUROPEAN JOURNAL OF CANCER 47/17 :2568-2575,2011
  • Gastroduodenal Complications After Concurrent Chemoradiation Therapy in Patients with Hepatocellular Carcinoma: Endoscopic Findings and Risk Factors.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 81/5 :1343-1351,2011
  • Adjuvant Hepatic Arterial Infusional Chemotherapy with 5-Fluorouracil and Cisplatin after Curative Resection of Hepatocellular Carcinoma
    ONCOLOGY 81/3-4 :184-191,2011
  • Non-invasive assessment of liver fibrosis: The gap between ideal and real
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 26/6 :937-939,2011
  • Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B
    ANTIVIRAL THERAPY 16/4 :469-477,2011
  • Risk Assessment of Hepatitis B Virus-Related Hepatocellular Carcinoma Development Using Liver Stiffness Measurement (FibroScan)
    HEPATOLOGY 53/3 :885-894,2011
  • The usefulness of liver stiffness measurement using FibroScan in chronic hepatitis C in South Korea: A multicenter, prospective study
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 26/1 :171-178,2011
  • 간세포암 환자에서 간동맥화학색전술 후 발생한 간십이지장 누공
    대한소화기학회지(The Korean Journal of Gastroenterology) 58/3 :149-152,2011
  • Prognostic Factors and 10-Year Survival in Patients with Hepatocellular Carcinoma After Curative Hepatectomy
    JOURNAL OF GASTROINTESTINAL SURGERY 15/4 :598-607,2011
  • Transient elastography in chronic hepatitis B: An Asian perspective
    WORLD JOURNAL OF GASTROENTEROLOGY 16/41 :5173-5180,2010
  • Toll-like Receptor Polymorphisms are not Associated with Liver Cirrhosis in Hepatitis B Virus Infected Korean Patients
    Hepato-Gastroenterology 57/104 :1351-1355,2010
  • Liver Stiffness Measurement in Combination With Noninvasive Markers for the Improved Diagnosis of B-viral Liver Cirrhosis
    Journal Of Clinical Gastroenterology 43/3 :267-271,2009
  • Liver stiffness measurement using FibroScan((R)) is influenced by serum total bilirubin in acute hepatitis
    Liver International 29/6 :810-815,2009

김승업

콘텐츠 처음으로 이동

네크워크 링크안내/사이트 정보